These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35419917)

  • 1. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
    Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
    J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L
    Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
    Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
    Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
    Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
    J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA FOXD2-AS1 Confers Radiosensitivity to Gastric Cancer Cells via miR-1913/SETD1A Axis.
    Guo F; Guo R; Zhang L
    Cytogenet Genome Res; 2022; 162(1-2):10-27. PubMed ID: 35354145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
    Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
    Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis.
    Shi W; Gao Z; Song J; Wang W
    Histol Histopathol; 2020 Sep; 35(9):1013-1021. PubMed ID: 32524576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis.
    Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X
    Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
    Zhao QS; Ying JB; Jing JJ; Wang SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
    Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
    Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis.
    Li YP; Liu Y; Xiao LM; Chen LK; Tao EX; Zeng EM; Xu CH
    Lab Invest; 2022 Jul; 102(7):691-701. PubMed ID: 35013529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p.
    Luo D; Salai A; Lv H; Wang Y; Gao Y
    Clin Transl Oncol; 2022 Oct; 24(10):1954-1963. PubMed ID: 35778646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
    Nong Q; Yu S; Hu H; Hu X
    Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.
    Cao L; Wang Y; Wang Q; Huang J
    Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.
    Liang Y; Wang H; Song R; Yin X
    Biomed Res Int; 2022; 2022():7723425. PubMed ID: 35782084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
    Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M
    J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.